The feasibility and efficacy of a community-based multifactorial intervention to improve the cardiovascular risk factor control among patients with type 2 diabetes: A 2-year cluster randomized trial-Reference-Cited by-同舟云学术

The feasibility and efficacy of a community-based multifactorial intervention to improve the cardiovascular risk factor control among patients with type 2 diabetes: A 2-year cluster randomized trial

Published:2022-12-23 Issue:51 Volume:101 Page:e31943
ISSN:1536-5964
Container-title:Medicine
language:en
Short-container-title:

Author:

Zhao Wenhui,Wang Yanlei,Cao Chenxiang,Zeng Ziqiang,Jin Lixia,Liu Zhaoxiang,Duan Min,Dong Yanan,Zhang Jinpin,Shuai Ying,Wang Na,Zhang Yajing,Deng Guixia,He Jiquan,Zhao Xinghua,Zheng Wenli,Yang Wenying,Xiao Jianzhong

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference17 articles.

1. Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients.;Ji;Am J Med,2013

2. Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999-2018.;Wang;JAMA,2021

3. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial.;Gaede;Diabetologia,2016

4. Research on multiple chronic conditions: where we are and where we need to go.;Tinetti;Med Care,2014

5. Cardiovascular risk factor targets and cardiovascular disease event risk in diabetes: a pooling project of the atherosclerosis risk in communities study, multi-ethnic study of atherosclerosis, and jackson heart study.;Wong;Diabetes Care,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Community-based type 2 diabetes care by lay village health workers in rural Lesotho: protocol for a cluster-randomized trial within the ComBaCaL cohort study (ComBaCaL T2D TwiC);Trials;2023-10-24

2. Community-based type 2 diabetes care by lay village health workers in rural Lesotho Protocol for a cluster-randomized trial within the ComBaCaL cohort study (ComBaCaL T2D TwiC);2023-10-05